P840: A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF PEGCETACOPLAN USING PRINCE TRIAL DATA VERSUS RAVULIZUMAB AND ECULIZUMAB IN COMPLEMENT-NAÏVE PATIENTS WITH PAROXYSMA...

por Wong, R., Fishman, J., Wilson, K., Yeh, M., Hakimi, Z., Yee, C., Huynh, L., Duh, M. S.
Publicado 2022

P1035: COUNTRY DIFFERENCES IN THE BURDEN OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

por Hwee, J., Kwon, N., Alfonso-Cristancho, R., Baylis, L., Requena, G., Du, S., Khanal, A., Huynh, L., Duh, M. S., Jakes, R. W.
Publicado 2022

P1034: HEALTHCARE UTILIZATION OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

por Hwee, J., Kwon, N., Alfonso-Cristancho, R., Baylis, L., Requena, G., Du, S., Khanal, A., Huynh, L., Duh, M. S., Jakes, R. W.
Publicado 2022